Abstract | BACKGROUND: Myeloid-derived suppressor cells (MDSC) have been shown to play a critical role in tumor-induced immunosuppression, in many mouse and human cancers. The aim of this study was to show that MDSC accumulation is tumor burden-dependent, and to investigate the role of the tumor-derived urokinase plasminogen activator (uPA) and its receptor (uPAR) on MDSC recruitment. MATERIALS AND METHODS: Levels of MDSC were assessed in tumor-bearers, and the ability to recruit MDSC by uPA was investigated in normal, tumor-bearers, uPAR(-/-), and CD11b(-/-) mice. uPAR expression in MDSC was also explored. RESULTS: MDSC accumulate to dramatic levels in tumor-bearers, and tumor-derived factors such as uPA also increase to great levels in circulation. MDSC can be recruited by uPA, and uPAR but not CD11b are required for such recruitment. CONCLUSION: MDSC accumulation is tumor burden-dependent, and tumor-derived factors such as uPA and its receptor uPAR play a role in their recruitment.
|
Authors | Dan Ilkovitch, Roberto Carrio, Diana M Lopez |
Journal | Anticancer research
(Anticancer Res)
Vol. 32
Issue 10
Pg. 4263-70
(Oct 2012)
ISSN: 1791-7530 [Electronic] Greece |
PMID | 23060546
(Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Chemical References |
- CD11 Antigens
- Receptors, Urokinase Plasminogen Activator
- Urokinase-Type Plasminogen Activator
|
Topics |
- Animals
- CD11 Antigens
(genetics)
- Carcinoma, Lewis Lung
(genetics, metabolism)
- Female
- Gene Knockdown Techniques
- Mammary Neoplasms, Animal
(genetics, metabolism)
- Melanoma
(genetics, metabolism)
- Mice
- Mice, Inbred BALB C
- Mice, Inbred C57BL
- Myeloid Cells
(metabolism)
- Receptors, Urokinase Plasminogen Activator
(analysis, metabolism)
- T-Lymphocytes, Regulatory
(metabolism)
- Tumor Burden
- Tumor Cells, Cultured
- Urokinase-Type Plasminogen Activator
(blood, genetics)
|